Gilead Sciences Inc.

Last update: Mar 25, 2026 at 04:53

About Gilead Sciences Inc.

Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs in infectious diseases, oncology, and other therapeutic areas across the United States, Europe, and international markets. Its portfolio centers on HIV treatments, including leading products like Biktarvy, Genvoya, Descovy, Odefsey, Sunlenca, and Yeztugo, the world's first twice-yearly HIV prevention therapy. The company also offers therapies for viral hepatitis such as Epclusa, Harvoni, Vemlidy, and Viread, alongside Veklury for COVID-19. In oncology and cell therapy, Gilead provides Yescarta, Tecartus, and Trodelvy for various cancers, as well as Livdelzi for primary biliary cholangitis. These products target life-threatening conditions in virology, liver diseases, hematology, inflammation, and respiratory areas, serving patients through innovative antiviral regimens, CAR-T cell therapies, and antibody-drug conjugates. Founded in 1987 and headquartered in Foster City, California, Gilead Sciences Inc. plays a pivotal role in advancing treatments for chronic and infectious diseases globally.

Dividend Overview

Dividend Yield

2.20%

Annual Dividend

$3.19

Frequency

Quarterly

Payout Ratio

46.61%

FCF Payout Ratio

42.33%

Stock Price

$138.11

52-Week Range

$93.37 – $157.29

Dividend Health Score

Very Safe

Dividend Health Assessment

GILD's dividend appears very safe. Strengths include a 46.6% earnings payout ratio & 42.3% fcf payout ratio. Areas of concern: Volatile profit margin stability.

Based on 15 of 15 metrics

Payout & Coverage

Very Safe

Earnings Payout Ratio

46.6%Very Safe

FCF Payout Ratio

42.3%Safe

CFO Payout Ratio

39.3%Safe

Interest Coverage

10.6xVery Safe

Balance Sheet

Safe

Net Debt / Total Assets

29.4%Safe

Current Ratio

1.6xSafe

Debt-to-Equity

112.9Caution

Profitability

Safe

Return on Equity

40.7%Very Safe

Operating Margin

37.4%Very Safe

Gross Margin

79.5%Very Safe

Profit Margin Stability

VolatileWarning

Dividend Track Record

Very Safe

11+ yrsVery Safe

NoneVery Safe

3.0%Caution

GrowingVery Safe

Dividend History (2016–2025)

GILD annual dividend per share and yield history

Earnings & Profitability

GILD earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

March 13, 2026

Next Payment Date

March 30, 2026

Dividend Growth

3-Year Dividend CAGR

2.67%

5-Year Dividend CAGR

3.04%

10-Year Dividend CAGR

9.37%

3-Year Total Growth

8.22%

5-Year Total Growth

16.18%

10-Year Total Growth

144.96%

Income Calculator

GILD Dividend Calculator

Number of Shares

Total Investment

$13,811.00

Annual Income

$319.00

Quarterly Income

$79.75

Monthly Income

$26.58

Similar Dividend Stocks

Stock	Yield	5Y CAGR	Price	Sector
GILD	2.20%	3.04%	$138.11	Healthcare
AMGNAmgen Inc.	2.68%	8.27%	$348.43	Healthcare
BMYBristol-Myers Squibb Company	4.17%	-9.52%	$57.39	Healthcare
BSXBoston Scientific Corporation	0.00%	N/A	$68.15	Healthcare
DHRDanaher Corporation	0.67%	14.93%	$190.10	Healthcare
MRKMerck & Co., Inc.	2.84%	6.75%	$116.37	Healthcare
PFEPfizer Inc.	6.46%	3.59%	$26.96	Healthcare
SYKStryker Corporation	0.97%	7.62%	$328.51	Healthcare

Frequently Asked Questions

What is GILD's current dividend yield?

Gilead Sciences Inc. (GILD) currently has a dividend yield of 2.20%, based on a stock price of $138.11 and an annual dividend of $3.19.

When is GILD's next dividend payment date?

GILD's next ex-dividend date is 2026-03-13 and the next payment date is 2026-03-30. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does GILD pay in dividends per year?

Gilead Sciences Inc. paid $3.16 per share in annual dividends in 2025. The dividends are paid quarterly.

Has GILD been increasing its dividend?

Gilead Sciences Inc. has grown its dividend at a 5-year CAGR of 3.04% and a 10-year CAGR of 9.37%.

Is GILD's dividend safe?

Gilead Sciences Inc. has a payout ratio of 46.61%. Its free cash flow payout ratio is 42.33%. A payout ratio below 60% is generally considered sustainable.

How is GILD's Dividend Health Score calculated?

The Dividend Health Score evaluates Gilead Sciences Inc.'s dividend sustainability across four categories: Payout & Coverage (40%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (20%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track GILD Dividends with OnlyDividends

What will GILD actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.